Literature DB >> 33657142

Seroprevalence of coronavirus disease 2019 (COVID-19) among health care workers from three pandemic hospitals of Turkey.

Gizem Alkurt1, Ahmet Murt2, Zeki Aydin3, Ozge Tatli4,5, Nihat Bugra Agaoglu1, Arzu Irvem6, Mehtap Aydin7, Ridvan Karaali8, Mustafa Gunes9, Batuhan Yesilyurt10, Hasan Turkez11, Adil Mardinoglu12,13, Mehmet Doganay14, Filiz Basinoglu15, Nurhan Seyahi2, Gizem Dinler Doganay4, Hamdi Levent Doganay1.   

Abstract

COVID-19 is a global threat with an increasing number of infections. Research on IgG seroprevalence among health care workers (HCWs) is needed to re-evaluate health policies. This study was performed in three pandemic hospitals in Istanbul and Kocaeli. Different clusters of HCWs were screened for SARS-CoV-2 infection. Seropositivity rate among participants was evaluated by chemiluminescent microparticle immunoassay. We recruited 813 non-infected and 119 PCR-confirmed infected HCWs. Of the previously undiagnosed HCWs, 22 (2.7%) were seropositive. Seropositivity rates were highest for cleaning staff (6%), physicians (4%), nurses (2.2%) and radiology technicians (1%). Non-pandemic clinic (6.4%) and ICU (4.3%) had the highest prevalence. HCWs in "high risk" group had similar seropositivity rate with "no risk" group (2.9 vs 3.5 p = 0.7). These findings might lead to the re-evaluation of infection control and transmission dynamics in hospitals.

Entities:  

Mesh:

Year:  2021        PMID: 33657142      PMCID: PMC7928442          DOI: 10.1371/journal.pone.0247865

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  19 in total

1.  Modeling shield immunity to reduce COVID-19 epidemic spread.

Authors:  Joshua S Weitz; Stephen J Beckett; Ashley R Coenen; David Demory; Marian Dominguez-Mirazo; Jonathan Dushoff; Chung-Yin Leung; Guanlin Li; Andreea Măgălie; Sang Woo Park; Rogelio Rodriguez-Gonzalez; Shashwat Shivam; Conan Y Zhao
Journal:  Nat Med       Date:  2020-05-07       Impact factor: 53.440

2.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

3.  Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19.

Authors:  Bicheng Zhang; Xiaoyang Zhou; Chengliang Zhu; Yuxiao Song; Fan Feng; Yanru Qiu; Jia Feng; Qingzhu Jia; Qibin Song; Bo Zhu; Jun Wang
Journal:  Front Mol Biosci       Date:  2020-07-03

4.  Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China.

Authors:  Aiping Wu; Yousong Peng; Baoying Huang; Xiao Ding; Xianyue Wang; Peihua Niu; Jing Meng; Zhaozhong Zhu; Zheng Zhang; Jiangyuan Wang; Jie Sheng; Lijun Quan; Zanxian Xia; Wenjie Tan; Genhong Cheng; Taijiao Jiang
Journal:  Cell Host Microbe       Date:  2020-02-07       Impact factor: 21.023

5.  Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome.

Authors:  Nelson Lee; P K S Chan; Margaret Ip; Eric Wong; Jenny Ho; Catherine Ho; C S Cockram; David S Hui
Journal:  J Clin Virol       Date:  2005-08-19       Impact factor: 3.168

6.  Antibody Response and Disease Severity in Healthcare Worker MERS Survivors.

Authors:  Abeer N Alshukairi; Imran Khalid; Waleed A Ahmed; Ashraf M Dada; Daniyah T Bayumi; Laut S Malic; Sahar Althawadi; Kim Ignacio; Hanadi S Alsalmi; Hail M Al-Abdely; Ghassan Y Wali; Ismael A Qushmaq; Basem M Alraddadi; Stanley Perlman
Journal:  Emerg Infect Dis       Date:  2016-06       Impact factor: 6.883

Review 7.  Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines.

Authors:  Hsin-I Shih; Chi-Jung Wu; Yi-Fang Tu; Chia-Yu Chi
Journal:  Biomed J       Date:  2020-05-30       Impact factor: 4.910

8.  Reasons for healthcare workers becoming infected with novel coronavirus disease 2019 (COVID-19) in China.

Authors:  J Wang; M Zhou; F Liu
Journal:  J Hosp Infect       Date:  2020-03-06       Impact factor: 3.926

9.  Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.

Authors:  Juanjuan Zhao; Quan Yuan; Haiyan Wang; Wei Liu; Xuejiao Liao; Yingying Su; Xin Wang; Jing Yuan; Tingdong Li; Jinxiu Li; Shen Qian; Congming Hong; Fuxiang Wang; Yingxia Liu; Zhaoqin Wang; Qing He; Zhiyong Li; Bin He; Tianying Zhang; Yang Fu; Shengxiang Ge; Lei Liu; Jun Zhang; Ningshao Xia; Zheng Zhang
Journal:  Clin Infect Dis       Date:  2020-11-19       Impact factor: 9.079

View more
  8 in total

1.  Seroprevalence in health care workers during the later phase of the second wave: Results of three hospitals in Serbia, prior to vaccine administration.

Authors:  Ljiljana Markovic-Denic; Marija Zdravkovic; Marko Ercegovac; Vladimir Djukic; Vladimir Nikolic; Danica Cujic; Dusan Micic; Tatjana Pekmezovic
Journal:  J Infect Public Health       Date:  2022-05-25       Impact factor: 7.537

2.  Seroprevalence of Anti-SARS-CoV-2 Antibodies among Municipal Staff in the Municipality of Prishtina.

Authors:  Bujar Gashi; Vesa Osmani; Rrezart Halili; Teuta Hoxha; Agron Kamberi; Nexhmedin Hoti; Riaz Agahi; Vlora Basha; Visar Berisha; Ilir Hoxha
Journal:  Int J Environ Res Public Health       Date:  2021-11-28       Impact factor: 3.390

3.  Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 ) IgG-antibody seroprevalence among quarantined population, during the first wave of COVID-19 pandemic, In North West Ethiopia (from 30 April to 30 May 2020).

Authors:  Fassikaw Kebede; Tsehay Kebede; Birhanu Kebede
Journal:  SAGE Open Med       Date:  2022-02-07

4.  Assessment of Diagnostic Specificity of Anti-SARS-CoV-2 Antibody Tests and Their Application for Monitoring of Seroconversion and Stability of Antiviral Antibody Response in Healthcare Workers in Moscow.

Authors:  Vera S Kichatova; Fedor A Asadi Mobarkhan; Ilya A Potemkin; Sergey P Zlobin; Oksana M Perfilieva; Vladimir T Valuev-Elliston; Alexander V Ivanov; Sergey A Solonin; Mikhail A Godkov; Maria G Belikova; Mikhail I Mikhailov; Karen K Kyuregyan
Journal:  Microorganisms       Date:  2022-02-12

Review 5.  Mitigating SARS-CoV-2 Transmission in Hospitals: A Systematic Literature Review.

Authors:  Chester Yan Hao Ng; Nicole-Ann Lim; Lena X Y Bao; Amy M L Quek; Raymond C S Seet
Journal:  Public Health Rev       Date:  2022-02-23

6.  Seroconversion of COVID-19 in Frontline Healthcare Workers in a Tertiary Care Hospital in Oman.

Authors:  Amal Altai; Zaina Al Maskari; Faryal Khamis; Issa Al Salmi; Padma Mohan J Kurup; Jalila Mohsin; Warda Al Habsi; Khadija Al Zadjali; Aisha Al Mamari; Hanan Al Busaidi; Amani Al Raisi; Ricky V Gutierrez; Adil Al Khusaibi
Journal:  Oman Med J       Date:  2022-07-31

7.  High Seroprevalence of SARS-CoV-2 in Mwanza, Northwestern Tanzania: A Population-Based Survey.

Authors:  Helmut A Nyawale; Nyambura Moremi; Mohamed Mohamed; Johnson Njwalila; Vitus Silago; Manuel Krone; Eveline T Konje; Mariam M Mirambo; Stephen E Mshana
Journal:  Int J Environ Res Public Health       Date:  2022-09-16       Impact factor: 4.614

Review 8.  The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 7).

Authors:  David Simons; Lion Shahab; Jamie Brown; Olga Perski
Journal:  Addiction       Date:  2020-11-17       Impact factor: 7.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.